Extrafoveal photostress recovery test in glaucoma and idiopathic central serous chorioretinopathy

British Journal of Ophthalmology

Volumn 82, Issue 9, 1998, Pages 1007-1012

  Horiguchi, Masayuki ^a   Ito, Yasuki ^a   Miyake, Yozo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OPEN ANGLE GLAUCOMA; PERIMETRY; PRIORITY JOURNAL; RETINA FOVEA; SCANNING LASER OPHTHALMOSCOPY; SCOTOMA;

EID: 0031656444     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.9.1007     Document Type: Article

References (38)

1. Magder H. Test for central serous retinopathy: based on clinical observation and trial. Am J Ophthalmol 1960;49:147-50.
2. Chiralis GA. Recovery time after macular illumination: as a diagnostic and prognostic test. Am J Ophthalmol 1962;53: 311-14.
3. Severin SL, Tour RL, Kershaw RH. Macular function and the photostress test 1. Arch Ophthalmol 1967;77:2-7.
4. Severin SL, Tour RL, Kershaw RH. Macular function and the photostress test 1. Arch Ophthalmol 1967;77:163-7.
5. Glaser JS, Savino PJ, Sumers KD, et al. The photostress recovery test in the clinical assessment of visual function. Am J Ophthalmol 1977;83:255-60.
6. Collins M, Brown B. Glare recovery and age related maculopathy. Clin Vis Sci 1986;4:145-53.
7. Wu G, Weiter JJ, Santos S, et al. The macular photostress test in diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 1990;108:1556-8.
8. Harnois C, Malenfant M, Dupont A, et al. Ocular toxicity of Anandron in patients treated for prostatic cancer. Br J Ophthalmol 1986;70:471-3.
9. Duncker G, Krasdel H. Ocular digitalis effects in normal subjects. Lens Eye Toxic Res 1990;7:281-303.
10. Sherman MD, Henkind P. Photostress recovery in chronic open angle glaucoma. Br J Ophthalmol 1988;72:641-54.
11. Parisi V, Bucci M. Visual evoked potentials after photostress in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1992;33:436-42.
12. Zuege P, Drance SM. Studies of dark adaptation of discrete paracentral retinal areas in glaucomatous subjects. Am J Ophthalmol 1967;64:56-63.
13. Lakowski R, Drance SM, Goldthwaite D. Chromatic extrafoveal dark adaptation function in normal and glaucomatous eyes. Mod Probl Ophthalmol 1976;17:304-10.
14. Jonas JB, Zach F-M, Naumann GOH. Dark adaptation in glaucomatous and nonglaucomatous optic nerve atrophy. Graefes Arch Clin Exp Ophthalmol 1990;228:321-5.
15. Franchi A, Magni L, Cordella M. VEP pattern after photostress: an index of macular function. Graefes Arch Clin Exp Ophthalmol 1987;225:291-4.
16. Lovasik JV. An electrophysiological investigation of the macular photostress test. Invest Ophthalmol Vis Sci 1983;24: 437-41.
17. Zabriskie NA, Kardon RH. The pupil photostress test. Ophthalmology 1994;101:1122-30.
18. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986,9:37-41.
19. Guyer DR, Yannuzzi LA, Slakter SJ, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol, 1994:112:1057-62.
20. Wolfensberger TJ, Mahieu I, Jarvis-Evans J, et al. Membrane-bound carbonic anhydrase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1994;35: 3401-7.
21. Kawasaki K, Mukoh S, Yonemura D, et al. Acetazolamide-induced changes of the membrane potentials of the retinal pigment epithelial cell. Doc Ophthalmol 1986;63:375-81.
22. Saito A, Miyake Y, Wang JX, et al. Foveal cone densitometer and changes in foveal cone pigments with aging. Nippon Ganka Gakkai Zasshi 1995;99:212-19.
23. Baker HD, Rushton WAH. The red-sensitive pigment in normal cones. J Physiol 1965;176:56-72.
24. Van Meel GJ, Smith VC, Pokorny J, et al. Foveal densitometry in central serous choroidopathy. Am J Ophthalmol 1984;98:359-68.
25. Quigley HA, Miller NR, George T. Clinical evaluation of nerve fiber layer atrophy as an indicator of glaucomatous optic nerve damage. Arch Ophthalmol 1980;98:1564-71.
26. Quigley HA, Addicks EM, Green WR, et al. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-49.
27. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982;100:135-46.
28. Quigley HA, Sanchez RM, Dukelberger GR, et al. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 1987;28:913-20.
29. Panda S, Jonas JB. Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma. Invest Ophthalmol Vis Sci 1992;33:2532-6.
30. Alvis DL. Electroretinographic changes in controlled chronic open-angle glaucoma. Am J Ophthalmol 1966;61: 121-31.
31. Ogata H. Electrophysiological study on glaucoma. Part I. Electroretinogram in primary glaucoma. Acta Soc Ophthalmol Jpn 1976;80:1555-64.
32. Fazio DT, Heckenlively HR, Martin DA, et al. The electroretinogram in advanced open-angle glaucoma. Doc Ophthalmol 1986;63:45-54.
33. Gills JP, Wadsworth JAC. Retrograde transsynaptic degeneration of the inner nuclear layer of the retina. Invest Ophthalmol Vis Sci 1967;6:437-48.
34. Dineen JT, Hendrickson AE. Age-correlated differences in the amount of retinal degeneration after striate cortex lesions in monkeys. Invest Ophthalmol Vis Sci 1981;21:749-5.
35. Dowling JE. Chemistry of visual adaptation in the rat. Nature (Lond) 1960;188:114-18.
36. Rushton WAH. Rhodopsin measurement and dark-adaptation in a subject deficient in cone vision. J Physiol (Lond) 1961;156:193-205.
37. Hollins M, Alpern M. Dark adaptation and visual pigment regeneration in human cones. J Gen Physiol 1973;62:430-47.
38. Eisner A. Multiple components in photopic dark adaptation. J Opt Soc Am 1986;3:655-66.